IRISYS, LLC
- Headquarters
- SAN DIEGO, CA
- Founded
- 2015
- Latest Form D
- $6.3M, Feb 2015
- Total capital
- $14.3M
- Federal grants
- $8M
- 50 awards · 1997–2023
- Private capital raised
- $6.3M
- 1 Form D · last Feb 2015
- 141 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 2 pending · first 2021
Capital timeline
Latest events
- Federal grantHealth and Human S · N01 · Societal Is A Small Business Concern For Dosage Form Development, Manufacture, And Stability Studies Of NCGC72$183K
- Federal grantHealth and Human S · N01 · Societal Is A Small Business Concern For Dosage Form Development, Manufacture, And Stability Studies Of NCGC72$566K
- Federal grantHealth and Human S · N02 · NExT DTP-23-019 GMP PRODUCTION OF 40MG CAPSULES OF Z-ENDOXIFEN$140K
- Federal grantHealth and Human S · N02 · Next DTP-23-017, Production Of 0.25MG Of Azatdc And Tdcyd Capsules$66K
- Federal grantHealth and Human S · N01 · This Task Order (to) Is To Provide Dosage Form Development, Manufacture And Stability Studies Of ORC-13661 For Phase II Clinical Trial$180K
- Federal grantHealth and Human S · N02 · Next DTP-22-018, Gmp Production Of 40 Mg Z-endoxifen (nsc 774768) Capsules$190K
- Federal grantHealth and Human S · N02 · Next DTP-22-013, Production Of TAK-243 Injectable For Clinical Use$639K
- Private capital raisedForm D · SEC · 1st filing$6.3M
Show 43 earlier federal awards
- Federal grantHealth and Human S · N01 · Production Of Ammonium Tetrathiomolibdate (attm) Capsules For Use In Clinical Trials$413K
- Federal grantHealth and Human S · N01 · Aza-tdc Capsules For Use In Clinical Trial$177K
- Federal grantHealth and Human S · N02 · Development & Manufacture Of Oral & Topical Dosage Forms - Novobiocin Capsule Production Base (task 1) 12 Months & Option 1 (task 2) A Cgmp Batch Shel$413K
- Federal grantHealth and Human S · N02 · Production Of A Cgmp Batch Of Triapine Injection$250K
- Federal grantHealth and Human S · N01 · Dosage Form Development, Manufacture, And Stability Studies Of AVE-1625 (drinabant. Drinabant) IV Bag Study$80K
- Federal grantHealth and Human S · N02 · Production Of Various Strength Of Ipdr Capsules For Clinical Use;$115K
- Federal grantHealth and Human S · N02 · Production Of Various Strength Of Ipdr Capsules For Clinical Use; Pop: 05/08/2020 - 05/07/2021$110K
- Federal grantHealth and Human S · N02 · Production Of Various Strength Of Aza-tdc Capsules For Clinical Use Pop: 03/16/2020 - 03/15/2021$97K
- Federal grantHealth and Human S · N02 · Production Of Various Strength Of Injectable LMP744 For Clinical Use; Pop: 02/14/2020 - 02/13/2021$513K
- Federal grantHealth and Human S · N02 · The Purpose Of This Task Order Is To Produce One Batch Of 10,000 Endoxifen Capsules, 40 Mg Per Capsule. (pop: 01/30/2020 To 06/29/2020)$100K
- Federal grantHealth and Human S · N02 · Development And Manufacture Of Oral And Topical Dosage Forms$10K
- Federal grantHealth and Human S · N02 · Production of LMP-744 Injection for Clinical Use$196K
- Federal grantHealth and Human S · N02 · Production of Triapine Injection for Clinical Use$138K
- Federal grantHealth and Human S · N02 · Production of Aza-TdC Capsules for Clinical Use$97K
- Federal grantHealth and Human S · N02 · Production of 5-Aza-TdC Capsules for Clinical Use$89K
- Federal grantHealth and Human S · N02 · Production of Td-Cyd Capsules for Clinical Use$86K
- Federal grantHealth and Human S · N02 · Production of 50 mL fill of 1 mg/mL injectable LMP-744$177K
- Federal grantHealth and Human S · N02 · manufacturing four (4) mg Aza-TdC Capsules$72K
- Federal grantHealth and Human S · N01 · Shelf-life evaluation$9K
- Federal grantHealth and Human S · N02 · Task Order 27: Study the Stabilizing Effect of StabilOx System on Tetra Thiomolybdate$30K
- Federal grantHealth and Human S · N02 · Indenos (LMP744, NSC 706744) for Injection$178K
- Federal grantHealth and Human S · N02 · Igf::ot::igf Production Of 600 Bottles Of Tetrahydrouridine Powder$73K
- Federal grantHealth and Human S · N02 · IPdR Capsules, 600mg Strength$81K
- Federal grantHealth and Human S · N02 · Conducting Assay, Purity profile, and Dissolution rate for Decitabine Capsules$8K
- Federal grantHealth and Human S · N02 · Production and Evaluation of the stability of Tetrathiomolibdate Capsules (Non GMP study)$18K
- Federal grantHealth and Human S · N02 · Igf::ot::igf$83K
- Federal grantHealth and Human S · N02 · Igf::ot:igf$77K
- Federal grantHealth and Human S · N02 · Z-Endoxifen HCl Capsules$240K
- Federal grantHealth and Human S · N02 · Igf::ot::igf$179K
- Federal grantHealth and Human S · N02 · Base Award$83K
- Federal grantHealth and Human S · N02 · Igf::ot::igf Task Order 15$85K
- Federal grantHealth and Human S · N02 · Igf::ot::igf Task Order 13$71K
- Federal grantHealth and Human S · N02 · Igf::ot::igf 4-THIO-2-DEOXYCYTIDINE, Manufacture A Batch Of 10 Mg Strength Capsules Under Gmp$60K
- Federal grantHealth and Human S · N02 · Igf::ot::igf Special Studies/analysis- Chemical/biological$71K
- Federal grantHealth and Human S · N02 · Igf::ot::igf Special Studies/analysis- Chemical/biological$156K
- Federal grantHealth and Human S · N02 · Igf::ot::igf Production Of 650 Bottles Of Tetrahydrouridine Powder, HHSN261201200009I/HHSN26100009, DTP-16-003, Development And Manufacture Of Oral And Topical Dosage Forms, Prbperiod Of Performance$67K
- Federal grantHealth and Human S · N01 · TAS::75 0849::TAS Development And Manufacture Of Oral And Toopical Dosage Forms$310K
- Federal grantHealth and Human S · N02 · TAS::75 0849::TAS Development And Manufacture Of Oral And Toopical Dosage Forms$327K
- Federal grantHealth and Human S · N02 · TAS::75 0849::TAS Development And Manufacture Of Oral And Toopical Dosage Forms$130K
- Federal grantHealth and Human S · N02 · TAS::75 0849::TAS Development And Manufacture Of Oral And Toopical Dosage Forms$62K
- Federal grantHealth and Human S · N02 · TAS::75 0849::TAS Development And Manufacture Of Oral And Toopical Dosage Forms$145K
- Federal grantHealth and Human S · N02 · TAS::75 0849::TAS Development And Manufacture Of Oral And Toopical Dosage Forms$283K
- Federal grantHealth and Human S · Phase I · Treatment Of Emotional Lability In Als Patients$99K
Federal awards are summed by year (50 awards); hover a bar for the split. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
212months
from IRISYS, LLC’s first federal award to its first private round.
- First federal award · Jun 1997
- Health and Human S · $99K
- First Form D · Feb 2015
- $6.3M · 1st Form D
- Awards before first raise
- 7 awards
An association in public records, not a cause or a prediction.
Founders and team
Researcher links verified by same-company patents and grants- GERALD J. YAKATANResearcherExecutive Officer, DirectorLinked by $109K in grants as PI
- ROBERT P. GIANNINIResearcherExecutive Officer, DirectorLinked by $6.8M in grants as PI
- BRIAN J. CONNELLYDirectorNamed in SEC Form D filings
- JIN P. WANGExecutive Officer, DirectorNamed in SEC Form D filings
- KEVIN P. XIEExecutive OfficerNamed in SEC Form D filings
- LUO P. YINGDirectorNamed in SEC Form D filings
Show all 7 people
- TOM P. EASTLINGDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 3- PendingLiposomal Anticancer CompositionsUSPTOApplication 17174291
- GrantedLiposomal Anticancer CompositionsUSPTOUS 11,033,520
- PendingLipsomal Anticancer CompositionsUSPTOApplication PCTUS2017049968
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .